BSX Stock Recent News
BSX LATEST HEADLINES
Boston Scientific will acquire medical device maker Silk Road Medical in a $1.16 billion deal, the companies said on Tuesday.
Silk Road Medical Inc.'s stock SILK, +1.31% was up 22.6% in pre-market trades on Tuesday after it agreed to be acquired by Boston Scientific Corp. BSX, -0.74% for $27.50 a share. The deal values the medical device company at just under $1.2 billion.
Acquisition adds innovative technology for stroke prevention to vascular portfolio MARLBOROUGH, Mass. , June 18, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Silk Road Medical, Inc. (Nasdaq: SILK), a medical device company that has developed an innovative platform of products to prevent stroke in patients with carotid artery disease through a minimally invasive procedure called transcarotid artery revascularization (TCAR).
Investors looking for stocks in the Medical - Products sector might want to consider either Haemonetics (HAE) or Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
In the most recent trading session, Boston Scientific (BSX) closed at $77.41, indicating a +0.34% shift from the previous trading day.
VelocityEHS Congratulates Boston Scientific, A 2024 Verdantix EHS Innovation Excellence Award Winner
VelocityEHS® celebrates Boston Scientific for being named the 2024 Verdantix EHS Innovation Excellence winner in the category Operational Risk Management.
In the latest trading session, Boston Scientific (BSX) closed at $75.57, marking a +0.76% move from the previous day.
Investors continue to be optimistic about Boston Scientific (BSX) due to its geographical expansions and impressive acquisitions.
Boston Scientific's (BSX) Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of GI and pulmonary treatment options.
Boston Scientific Boston Scientific (NYSE: BSX) saw its net income expand by $0.9 billion or 145% y-o-y to $1.6 billion in 2023. This can primarily be attributed to an expansion of its operating margin and lower taxes.